RETRACTED: Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the National Health and Nutrition Examination Survey linked mortality file

Poole-Wilson P . The prevention of cardiovascular disease worldwide: Whose task and WHO's task? Clin Med 2005; 5: 379–384.

Hicks KA Hung H Mahaffey KW et al. Standardized definitions for cardiovascular and stroke end point events in clinical trials. Clinical Data Interchange Standards Consortium 2014. www.cdisc.org (accessed 20 January 2016).

Mozaffarian D Benjamin EJ Go AS et al. Heart disease and stroke statistics–2016 update. A report from the American Heart Association. Circulation 2016; 133: e38–e360.

Sidney S Quesenberry CP Jaffe MG et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol 2016; 1: 594–599.

Kotseva K De Bacquer D De Backer G et al. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol 2016; 23: 2007–2018.

Ford ES Ajani UA Croft JB et al. Explaining the decrease in US deaths from coronary disease, 1980–2000. N Engl J Med 2007; 356: 2388–2398.

Piepoli MF Hoes AW Agewall S et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol 2016; 23: Np1–Np96.

Perk J De Backer G Gohlke H et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635–1701.

Eckel RH Jakicic JM Ard JD et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. Circulation. Epub 12 November 2013. DOI: 10.1161/01.cir.0000437740.48606.d1.

Stampfer MJ Hu FB Manson JE et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000; 343: 16–22.

Deligiannis A Björnstad H Carre F et al. ESC Study Group of Sports Cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil 2006; 13: 687–694.

Lindsay AC Foale RA Warren O et al. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol 2005; 104: 230–232.

Aryana A Williams MA . Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty? Int J Cardiol 2007; 118: 141–144.

Ezzati M Henley SJ Thun MJ et al. Role of smoking in global and regional cardiovascular mortality. Circulation 2005; 112: 489–497.

Ambrose JA Barua RS . The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004; 43: 1731–1737.

Lakier JB . Smoking and cardiovascular disease. Am J Med 1992; 93: S8–S12.

Jones RT . Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42: 58S–63S.

Rezkalla S Stankowski R Kloner RA . Cardiovascular effects of marijuana, Los Angeles, CA: Sage, 2016.

Beaconsfield P Ginsburg J Rainsbury R . Marihuana smoking: Cardiovascular effects in man and possible mechanisms. N Engl J Med 1972; 287: 209–212.

Benowitz NL Jones RT . Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther 1975; 18: 287–297.

Sidney S . Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002; 42: 64S–70S.

Aronow WS Cassidy J . Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharmacol Ther 1975; 17: 549–554.

National Center for Health Statistics. Office of Analysis and Epidemiology, Public-use Linked Mortality File, 2015. Hyattsville, Maryland. Available at: http://www.cdc.gov/nchs/data_access/data_linkage/mortality.htm (accessed 14 December 2016).

Wadsworth EJ Moss SC Simpson SA et al. Factors associated with recreational drug use. J Psychopharmacol 2004; 18: 238–248.

Borgan Ø. Nelson–Aalen estimator. In: Armitage P and Colton T (eds.) Encyclopedia of bio-statistics. Hoboken, NJ: John Wiley & Sons, 2005.

Ferdinand KC . Substance abuse and hypertension. J Clin Hypertens (Greenwich) 2000; 2: 37–40.

Zachariah SB . Stroke after heavy marijuana smoking. Stroke 1991; 22: 406–409.

Mittleman MA Lewis RA Maclure M et al. Triggering myocardial infarction by marijuana. Circulation 2001; 103: 2805–2809.

Collins J Higginson J Boyle DM et al. Myocardial infarction during marijuana smoking in a young female. Eur Heart J 1985; 6: 637–638.

Go AS Mozaffarian D Roger VL et al. Heart disease and stroke statistics–2013 update. Circulation 2013; 127: e841–e841.

Arnett JJ . The developmental context of substance use in emerging adulthood. J Drug Issues 2005; 35: 235–254.